Zusammenfassung
Die Inzidenz primärer maligner Hirntumoren ist bei Patienten in fortgeschrittenem Alter in den letzten Jahrzehnten deutlich angestiegen. Kürzlich publizierte das amerikanische National Cancer Institut (1999) die altersspezifischen Inzidenzraten von Hirntumoren mit einem Anstieg ab dem 50. Lebensjahr und Höchstwerten von 20/100.000/Jahr in der Altersgruppe der 70- bis 79-Jährigen (Stat Bite 1999).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16: 859–863
Ampil F, Fowler M, Kim K (1992) Intracranial astrocytoma in elderly patients. J Neurooncol 12: 125–130
Bamberg M, Hess CF (1992) Radiation therapy of malignant gliomas. Onkologie 15: 178–189
Barker FG 2nd, Prados MD, Chang SM et al. (1996) Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84: 442–448
Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, MacDonald DR, Cairncross JG (1994) A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29: 835–839
Blay JY, Conroy T, Chevreau C et al. (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16: 864–871
Brada M, Hjiyiannakis D, Hines F, Traish D, Ashley S (1998) Short intensive primary chemotherapy and radiotherapy in sporadic primary CND lymphoma. Int J Radiat Oncol Biol Phys 40: 1157–1162
Fine HA, Mayer RJ (1993) Primary central nervous system lymphoma. Ann Intern Med 119: 1093–1104
Freilich RJ, Delattre JY, Monjour A, DeAngelis LM (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients [see comments]. Neurology 46: 435–439
Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K (1989) High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 70: 190–194
Glantz MJ, Cole BF, Recht L, Akerley W, Mills P, Saris S, Hochberg F, Calabresi P, Egorin MJ (1998) High-dose methotrexate for patients with nonleucemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncology 16: 1561–1567
Glass J, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81: 188–195
Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L (1995) Age influences chemotherapy response in astrocytomas. Neurology 45: 929–933
Greenberg MS (1994) Handbook of neurosurgery, 3rd ed. Greenberg Graphics, Lakeland, Florida
Hoegler DB, Davey P(1997) A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 3: 201–204
Kortmann RD, Hess CF, Jany R, Bamberg M (1994) Repeated CT examinations in limited volume irradiation of brain tumors: quantitative analysis of individualized (CT-based) treatment plans. Radiother Oncol 30: 171–174
Kortmann RD, Bamberg M, Budach W, Hoffmann W, Herrlinger U, Clemens MR (1996) Radiotherapy alone or combined radio-/chemotherapy for primary non-Hodgkin’s lymphomas of the central nervous system. Tumordiagn Ther 17: 106–115
Kortmann RD, Becker G, Kühl J, Bamberg M (1998) Strahlentherapie bei malignen Gliomen. Onkologe 4: 608–617
Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42: 981–987
Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld D, Nelson JS (1988) Combined modality approach to treatment of malignant gliomas-re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 6: 279–284
Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ (1992) Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315 [see comments]. Int J Radiat Oncol Biol Phys 23: 9–17
Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsay F, Roman-Goldstein S, Braziel R, Dana B(1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580–1590
Radhakrishnan K, Mokri B, Parisi JE, O’Fallon WM, Sunku J, Kurland LT (1995) The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 37: 67–73
Sandor V, Stark-Vancs V, Pearson D et al. (1998) Phase II trial of chemotherapy alone for primary CNS and intraocular ymphoma. J Clin Oncol 16: 3000–3006
Sant M, Crosignani P, Bordo BM, Nicola G, Bianchi M, Berrino F (1988) Incidence and survival of brain tumors: a population-based study. Tumori 74: 243–252
Stat Bite (1999) Age specific incidence of brain and central nervous system tumors. J Natl Cancer Inst 91: 1535
Stein M, Kuten A, Ben-Arieh Y, Cohen Y, Haim N (1991) Primary brain lymphoma. Harefuah 121: 4–8
Thomas R, James N, Guerrero D, Ashley S, Gregor A, Brada M (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33: 113–116
Villa S, Vinolas N, Verger E, Yaya R, Martinez A, Gil M, Moreno V, Caral L, Graus F (1998) Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42: 977–980
Walker MD, Strike TA, Sheline SE (1979) An analysis of dose-effect relationship of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725–1731
Wiestler OD, Schmidt MC (1998) Neuropathologie maligner Gliome. Onkologe 4: 580–588
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hochstetter, A., Hofer, S., Kortmann, R.D., Herrmann, R., Kalff, R. (2002). ZNS-Tumoren. In: Höffken, K., Wedding, U., Kolb, G. (eds) Geriatrische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56391-1_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-56391-1_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63154-2
Online ISBN: 978-3-642-56391-1
eBook Packages: Springer Book Archive